RxDoctor Payments Data

Victor Okunrintemi

Interventional Cardiology · Huntsville, ALNPI 1578054854

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.2%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Boston Scientific at 34.0% of the total. Reporting peaked in 2024 at $6,523 and has fallen 88.0% since, to $785 in 2025.

$11,807in general payments, 2019–2025

Across 178 payments — averaging $66.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • Abbott$3K
  • Medtronic$1K
  • Terumo Medical Corporation$1K
  • Amgen$588
  • Abiomed$243
  • plus $2K from 16 others

What the payments were for

  • Grants$2,46121%
  • Travel & lodging$2,64622%
  • Food & beverage$6,63456%
  • Education$661%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,807 in reported general payments places this provider in the 70th percentile of 109 interventional cardiology providers in Alabama.

See all interventional cardiology providers in Alabama

Other interventional cardiology in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →